Tabla de Contenidos: “…How Nicole Wojno Smith, VP of Marketing at Tackle, Got Her First Executive Role by Leveling Up Within Her Then-organization -- How Smith "leveled Up" by Building a Partnership with the C-level Team -- Mastering Data-driven Storytelling Around Business Objectives -- Gain a Deeper Understanding of Cross-functional Partners and Their Roles -- Partner Closely with Your Finance Leadership (unless You're The CFO -- in That Case, Partner with Every Other Executive Team) -- Start Unofficially Recruiting Your "bench" Dream Team for Your Department -- Leveling Up in the Engineering Side of the Business: Jeff Ammons -- Learning to Let Go of Being the One to Write Code and Shifting to Empowering His Team -- On Internal Promotions: Nick Mehta's Perspective as Ceo of Gainsight -- Getting Hired: Landing The role -- Internal Promotions to executive Are Possible, but Not at Every Company -- Chapter Five Get The offer and Secure Your Executive Seat -- Find Your First (or Next) Executive Role -- Interviewing For your Executive Role -- Navigating The often Byzantine Startup Hiring Process -- The Interview Process -- Understand the Presentation Tech Stack and Practice Your Presentation With friends -- Meeting With the CEO: Understand Their Vision -- When the Startup's Hiring Process Goes Awry -- Getting The offer -- Compensation Breakdown -- Negotiating The offer -- Do Your Research -- Risk Vs. …”

Tabla de Contenidos: “…Contemporary Methods in Goal Activation and Measurement -- Contemporary Methods in Emotion Elicitation and Measurement -- Methods for Examining Goal/Emotion Interactions -- Concluding Thoughts -- Appendix A -- Cognition Study -- Appendix B -- Life Experiences -- Breakup -- Appendix C -- References -- Chapter 13: Forecasting and Prediction -- Forecasting and Prediction -- Quantitative Forecasting -- The Role of the Judge in Prediction -- References -- Chapter 14: Understanding Daily Life with Ecological Momentary Assessment -- Introduction -- What Is Ecological Momentary Assessment? …”

“…In The Accidental CIO, veteran software developer-turned-executive Scott Millett delivers an essential playbook to becoming an impactful, strategic leader at any stage of your IT leadership journey from your earliest aspirations to long time incumbents in director and C-suite roles. You'll find a wealth of hands-on advice for tackling the many challenges and paradoxes that face technology leaders, from creating an aligned IT strategy, defining a target architecture, designing a balanced operating model, and leading teams and executing strategy. …”

Tabla de Contenidos: “…Appendix B: OBLS Mnemonics -- Appendix C: Resources -- Appendix D: American Heart Association Opioid-Associated Emergency Algorithm for Healthcare Providers -- Appendix E: Post-ROSC Care Checklist IH -- Appendix F: Post-ROSC Care Checklist OH -- Appendix G: Venous Thromboembolism Prophylaxis Following Stroke -- Appendix H: Megacode Checklist OH Basic -- Appendix I: Megacode Checklist OH Advanced -- Appendix J: Megacode Checklist IH -- Appendix K: Institutional Preparedness -- Appendix L: OBLS Drug List…”

Tabla de Contenidos: “…14 Review of the FDA Task Force Report "Fialuridine: Hepatic and Pancreatic Toxicity -- OBJECTIVE OF FDA REVIEW -- TASK FORCE COMPOSITION -- METHODOLOGY -- Selected Laboratory Observations -- Clinical Events -- RESULTS -- Animal Pharmacology and Toxicology Studies -- Overview of Laboratory Events in Studies Prior to H3X-MC-PPPC -- Attribution of Toxicity to Adverse Clinical Events -- Review of Adverse Clinical Events in Trial R89-001-01 -- Review of Adverse Clinical Events in Trial R90-001-01 -- Subject 401 -- Subject 406 -- Subject 408 -- Subject 101 -- Subject 409 -- Review of Adverse Clinical Events in Trial R91-010-01 -- Subject 4D -- Subject 6B -- Subject 1C -- Subject 6A -- Subject 3B -- RECOMMENDATIONS -- Clinical Trial Design and Execution -- Consideration of Control Groups -- Prospective Evaluation of End Points -- Assess Expected Incidence of Death or Serious Events in The Study Population in The Absence of The Investigational Drug -- Observed Effects on Identified End Points Should Be Included in The Investigator Brochure and Presumed to Be Drug-Related... -- Extent of Follow-Up -- Adequate Safety Monitoring -- Reporting Requirements -- Summarization of All Existing Safety Data -- FDA Record Keeping -- Further Review of Fiau Toxicity -- 15 Review Of "Report To The Advisory Committee To The Director, National Institutes Of Health -- OBJECTIVE OF THE NIH REVIEW -- Question 1-Why Were The Fiau Studies Conducted? …”

Ver edición digitalizada del t.1
Ver edición digitalizada del t.2
Ver edición digitalizada del t.3
Ver edición digitalizada del t.4
Ver edición digitalizada del t.5
Ver edición digitalizada del t.8